TG and hydrops fetalis: Thyroid hormone replacement therapy of patients with HF or atrial fibrillation has shown to provide significant cardiovascular benefit (Pingitore et al. 2008; Wandell et al. 2017; Moruzzi et al. 1996; Hamilton and Stevenson 1996; Hamilton et al. 1998).